Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Tel Aviv Sourasky Medical Center

Status: Unknown

Conditions: Edema; Trismus; Pain

Treatments: Drug: Etodalac, Etoricoxib and Dexamethasone

Study type: Interventional

Funder types: Other

Identifiers

NCT00793052

TASMC-08-BS-062-CTIL

Details and patient eligibility

About

The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who are refered for third molar extraction to our center
• Must be able to swallow tablets

Exclusion criteria

• Diabetes mellitus
• Thyroid diseases
• Cardiovascular diseases
• renal diseases
• hepatic diseases
• respiratory system diseases
• adrenal diseases
• Allergy to Etodalac, Etoricoxib or Dexamethasone
• Gastric ulcers
• psychiatric diseases
• Pregnant or breast feeding womans

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Triple Blind

---

80 participants in 1 patient group

A

Experimental group

Treatment:

Drug: Etodalac, Etoricoxib and Dexamethasone